Weekly Recap: Decipher studies at ASTRO 2026 and ARKG buys Veracyte, Inc.

Veracyte, Inc. (NASDAQ:VCYT) will showcase eight Decipher-focused studies, including Decipher Prostate Genomic Classifier data, at ASTRO 2026 in Boston, while ARK Genomic Revolution ETF (ARKG) boosted its biotech stake with roughly $3 million more of VCYT shares.Previous Week RecapThis is an AI-gen…